{"id":"fenalamide","rwe":[{"pmid":"5806515","year":"1969","title":"[Gas chromatographic findings on the impurities of fenalamide and determination of their structure].","finding":"","journal":"Il Farmaco; edizione pratica","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"femamide","offLabel":[],"synonyms":["fenalamide","femamide","phemamide","spasmamide"],"timeline":[],"approvals":[],"brandName":"Femamide","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"While the exact details of how Femamide works are not well understood, it is believed to bind to a specific protein or receptor in the body, which triggers a series of chemical reactions that ultimately lead to its therapeutic effects. This process can help to modify the body's response to certain conditions, leading to improved health outcomes. However, more research is needed to fully understand the mechanism of action of Femamide.","oneSentence":"Femamide is thought to work by interacting with a specific molecular target to produce a therapeutic effect.","technicalDetail":"Femamide's mechanism of action is not well characterized, but it is likely to involve the modulation of a specific molecular target, such as a receptor or enzyme, which triggers a cascade of downstream effects that contribute to its therapeutic effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1143","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FENALAMIDE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:25:19.714024","biosimilars":[],"competitors":[],"genericName":"fenalamide","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"9D63492A3N","CHEBI":"CHEBI:135421","INN_ID":"2326","UMLSCUI":"C0060146","ChEMBL_ID":"CHEMBL2106562","KEGG_DRUG":"D04138","PUBCHEM_CID":"20683","MESH_SUPPLEMENTAL_RECORD_UI":"C004341"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":1,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"1969 May","pmid":"5806515","title":"[Gas chromatographic findings on the impurities of fenalamide and determination of their structure].","journal":"Il Farmaco; edizione pratica"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Femamide, also known as Fenalamide, is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it is not known whether it is patented or generic. The indications for which it is approved are also unknown. Further research is needed to understand its mechanism of action and key safety considerations. As a result, Femamide is not widely recognized in the pharmaceutical industry.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}